When to start renal replacement therapy in acute kidney injury: What are we waiting for?
J Intensive Med
; 4(3): 341-346, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-39035622
ABSTRACT
Acute kidney injury remains a serious condition with a high mortality risk. In the absence of any new drugs, renal replacement therapy (RRT) is the most important treatment option. Randomized controlled trials have concluded that in critically ill patients without an emergency indication for RRT, a watchful waiting strategy is safe; however, further delays in RRT did not seem to confer any benefit, rather was associated with potential harm. During this process, balancing the risks of complications due to an unnecessary intervention with the risk of not correcting a potentially life-threatening complication remains a challenge. Dynamic renal function assessment, especially dynamic assessment of renal demand-capacity matching, combined with renal biomarkers such as neutrophil gelatinase-associated lipocalin and furosemide stress test, is helpful to identify which patients and when the patients may benefit from RRT.
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
J Intensive Med
Año:
2024
Tipo del documento:
Article
País de afiliación:
China